Winningham Rick E (CIK 0001302443)

Latest company ownership

Shares held
825,391
Last filed at
Aug 19, 2014
Confidence Score
50.0
2025Q4
Confidence Score History
2012Q3 2025Q4
Shares held
92,567
Last filed at
Nov 21, 2025
Confidence Score
39.3
2025Q4
Confidence Score History
2015Q1 2025Q4
Shares held
8,893
Last filed at
Nov 20, 2025
Confidence Score
36.0
2025Q4
Confidence Score History
2016Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 19, 2025 Nov 21, 2025 Theravance Biopharma, Inc. CEO Sell 37.5 -56,817 -3.12% ✗ $1M
Nov 18, 2025 Nov 20, 2025 Jazz Pharmaceuticals plc Director Sell 20.0 -5,500 -38.21% ✗ $994.7K
Aug 20, 2025 Aug 22, 2025 Theravance Biopharma, Inc. CEO Sell 45.0 -15,394 -0.84% ✗ $206.1K
Aug 7, 2025 Aug 11, 2025 Jazz Pharmaceuticals plc Director Sell 95.0 +1,702 13.41% ✗ $200.8K
May 20, 2025 May 22, 2025 Theravance Biopharma, Inc. CEO Sell 45.0 -15,364 -0.82% ✗ $145.2K
Feb 20, 2025 Feb 24, 2025 Theravance Biopharma, Inc. CEO Sell 40.0 -35,129 -1.84% ✗ $339.3K
Nov 20, 2024 Nov 22, 2024 Theravance Biopharma, Inc. CEO Sell 45.0 -15,997 -0.83% ✗ $159.5K
Aug 20, 2024 Aug 22, 2024 Theravance Biopharma, Inc. CEO Sell 45.0 -15,997 -0.83% ✗ $131.5K
Aug 2, 2024 Aug 6, 2024 Jazz Pharmaceuticals plc Director Sell 95.0 +2,247 21.51% ✗ $165.2K
May 20, 2024 May 22, 2024 Theravance Biopharma, Inc. CEO Sell 45.0 -15,997 -0.82% ✗ $145.6K
Feb 20, 2024 Feb 22, 2024 Theravance Biopharma, Inc. CEO Sell 40.0 -37,196 -2.20% ✗ $331.8K
Nov 20, 2023 Nov 22, 2023 Theravance Biopharma, Inc. CEO Sell 45.0 -15,804 -0.93% ✗ $163.9K
Aug 20, 2023 Aug 22, 2023 Theravance Biopharma, Inc. CEO Sell 45.0 -15,804 -0.92% ✗ $153.3K
Aug 11, 2023 Aug 15, 2023 Jazz Pharmaceuticals plc Director Sell 95.0 +1,834 21.30% ✗ $171.5K
May 20, 2023 May 23, 2023 Theravance Biopharma, Inc. CEO Sell 45.0 -15,804 -0.91% ✗ $177.2K
Feb 20, 2023 Feb 22, 2023 Theravance Biopharma, Inc. CEO Sell 40.0 -37,420 -2.59% ✗ $390.7K
Dec 13, 2022 Dec 16, 2022 Theravance Biopharma, Inc. CEO Sell 20.0 -59,000 -3.93% ✗ $559.5K
Nov 20, 2022 Nov 22, 2022 Theravance Biopharma, Inc. CEO Sell 42.5 -15,804 -1.04% ✗ $171.5K
Aug 19, 2022 Aug 23, 2022 Theravance Biopharma, Inc. CEO Sell 42.5 -15,804 -1.03% ✗ $147.6K
Aug 5, 2022 Aug 9, 2022 Jazz Pharmaceuticals plc Director Sell 95.0 +1,472 20.62% ✗ $165.9K
May 20, 2022 May 24, 2022 Theravance Biopharma, Inc. CEO Sell 45.0 -11,025 -0.71% ✗ $96.4K
Feb 18, 2022 Feb 23, 2022 Theravance Biopharma, Inc. CEO Sell 42.5 -22,710 -1.63% ✗ $218.2K
Nov 19, 2021 Nov 23, 2021 Theravance Biopharma, Inc. CEO Sell 45.0 -11,404 -0.81% ✗ $95.3K
Aug 20, 2021 Aug 24, 2021 Theravance Biopharma, Inc. CEO Sell 45.0 -11,404 -0.80% ✗ $160.2K
Aug 6, 2021 Aug 10, 2021 Jazz Pharmaceuticals plc Director Sell 22.5 -1,306 -15.47% ✗ $193.2K
May 20, 2021 May 24, 2021 Theravance Biopharma, Inc. CEO Sell 32.5 -11,404 -0.80% ✗ $203K
Feb 20, 2021 Feb 23, 2021 Theravance Biopharma, Inc. CEO Sell 17.5 -110,348 -7.18% ✗ $2.1M
Nov 20, 2020 Nov 24, 2020 Theravance Biopharma, Inc. CEO Sell 22.5 -13,946 -1.01% ✗ $240K
Aug 20, 2020 Aug 24, 2020 Theravance Biopharma, Inc. CEO Sell 30.0 -13,946 -1.00% ✗ $254.1K
Aug 6, 2020 Aug 10, 2020 Jazz Pharmaceuticals plc Director Sell 95.0 +1,774 40.10% ✗ $117.2K
May 20, 2020 May 22, 2020 Theravance Biopharma, Inc. CEO Sell 30.0 -13,946 -0.99% ✗ $371.9K
Feb 20, 2020 Feb 24, 2020 Theravance Biopharma, Inc. CEO Sell 17.5 -96,850 -6.44% ✗ $2.5M
Nov 20, 2019 Nov 22, 2019 Theravance Biopharma, Inc. CEO Sell 32.5 -8,678 -0.74% ✗ $152.7K
Aug 20, 2019 Aug 22, 2019 Theravance Biopharma, Inc. CEO Sell 32.5 -8,678 -0.73% ✗ $186.7K
Aug 8, 2019 Aug 12, 2019 Jazz Pharmaceuticals plc Director Sell 95.0 +1,194 36.97% ✗ $98.5K
May 20, 2019 May 22, 2019 Theravance Biopharma, Inc. CEO Sell 32.5 -8,678 -0.73% ✗ $172.2K
Feb 20, 2019 Feb 22, 2019 Theravance Biopharma, Inc. CEO Sell 20.0 -13,477 -1.12% ✗ $363.9K
Nov 20, 2018 Nov 21, 2018 Theravance Biopharma, Inc. CEO Sell 20.0 -15,557 -1.72% ✗ $385.7K
Aug 20, 2018 Aug 22, 2018 Theravance Biopharma, Inc. CEO Sell 20.0 -15,557 -1.69% ✗ $419.3K
Aug 9, 2018 Aug 13, 2018 Jazz Pharmaceuticals plc Director Sell 17.5 -15,144 -75.37% ✗ $2.9M
May 20, 2018 May 22, 2018 Theravance Biopharma, Inc. CEO Sell 17.5 -67,617 -6.85% ✗ $1.6M
Feb 20, 2018 Feb 22, 2018 Theravance Biopharma, Inc. CEO Sell 20.0 -13,005 -1.45% ✗ $378.3K
Aug 10, 2017 Aug 14, 2017 Jazz Pharmaceuticals plc Director Sell 90.0 +703 6.77% ✗ $94.2K
Aug 11, 2017 Aug 11, 2017 Theravance Biopharma, Inc. CEO Buy 82.5 +10,000 1.17% ✗ $245K
Jun 1, 2017 Jun 2, 2017 Jazz Pharmaceuticals plc Director Sell 20.0 -5,000 -32.49% ✗ $750K
May 20, 2017 May 23, 2017 Theravance Biopharma, Inc. CEO Sell 20.0 -15,460 -1.77% ✗ $569.4K
Feb 20, 2017 Feb 22, 2017 Theravance Biopharma, Inc. CEO Sell 17.5 -33,264 -3.68% ✗ $1.1M
Nov 20, 2016 Nov 22, 2016 Theravance Biopharma, Inc. CEO Sell 30.0 -8,360 -0.95% ✗ $267.2K
Aug 15, 2016 Aug 17, 2016 Jazz Pharmaceuticals plc Director Sell 22.5 -633 -3.95% ✗ $86.4K
Aug 14, 2015 Aug 17, 2015 Theravance Biopharma, Inc. CEO Buy 92.5 +80,000 7.24% ✗ $948.9K
Feb 20, 2015 Feb 24, 2015 Theravance Biopharma, Inc. CEO Sell 43.8 -1,480 -0.28% ✗ $28.9K
May 9, 2014 May 12, 2014 Innoviva, Inc. CEO Sell 17.5 -50,225 -6.67% ✗ $1.3M
Feb 20, 2014 Feb 24, 2014 Innoviva, Inc. CEO Sell 20.0 -9,297 -1.37% ✗ $371.7K
Nov 20, 2013 Nov 22, 2013 Innoviva, Inc. CEO Sell 20.0 -10,046 -1.46% ✗ $365.7K
Sep 12, 2013 Sep 13, 2013 Innoviva, Inc. CEO Sell 35.0 -22,353 -3.14% ✓ $894.8K
Aug 20, 2013 Aug 22, 2013 Innoviva, Inc. CEO Sell 20.0 -10,046 -1.39% ✗ $360.6K
May 20, 2013 May 22, 2013 Innoviva, Inc. CEO Sell 20.0 -10,046 -1.39% ✗ $371.8K
Apr 30, 2013 May 2, 2013 Innoviva, Inc. CEO Sell 3.8 -255,532 -26.15% ✓ $8.6M
Feb 20, 2013 Feb 22, 2013 Innoviva, Inc. CEO Sell 22.5 -10,655 -1.77% ✗ $235.5K
Aug 20, 2012 Aug 22, 2012 Innoviva, Inc. CEO Sell 20.0 -10,681 -1.81% ✗ $288.5K
Aug 3, 2012 Aug 7, 2012 Innoviva, Inc. CEO Sell 20.0 -75,749 -11.36% ✓ $2.1M